We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

New Drug Delivery System Targets Diseases at a Genetic Level

News   Dec 06, 2017 | Original story from University of Connecticut

 
New Drug Delivery System Targets Diseases at a Genetic Level

Enzyme-triggered degradation of a drug loaded peptide-crosslinked nucleic acid nanocapsule. First a peptide is crosslinked at the nanoparticle surface (1), then an enzyme recognizes the peptide crosslinker (2), and finally the enzyme cleavage leads to the release of the drug and any intact DNA (3). Credit: (Artwork by Joseph Luciani/UConn)

 
 
 

RELATED ARTICLES

A Research Partnership to Find Treatments for Neurological Disorders

News

BioMotiv and Cure Network Dolby Acceleration Partners launch a collaboration to find better treatments for brain disorders.

READ MORE

Novel Histone-Tracking Tool Unlocks New Insights into Epigenetic Cellular Memory

News

The way daughter cells inherit histones is a highly controlled process, and may be highly influential on development.

READ MORE

New 3D-printed Device Could Help Treat Spinal Cord Injuries

News

Researchers hope their neuronal stem cell scaffold could be surgically implanted to help spinal cord injury patients.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Cell Science Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE